Your browser doesn't support javascript.
loading
Molecular Design and Synthesis of New 3,4-Dihydropyrimidin-2(1H)-Ones as Potential Anticancer Agents with VEGFR-2 Inhibiting Activity.
Mostafa, Amany S; Bayoumi, Waleed A; El-Mesery, Mohamed; Elgaml, Abdelaziz.
Affiliation
  • Mostafa AS; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • Bayoumi WA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • El-Mesery M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamassa, Egypt.
  • Elgaml A; Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Anticancer Agents Med Chem ; 19(3): 310-322, 2019.
Article in En | MEDLINE | ID: mdl-30019649

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Drug Design / Vascular Endothelial Growth Factor Receptor-2 / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Anticancer Agents Med Chem Journal subject: ANTINEOPLASICOS / QUIMICA Year: 2019 Document type: Article Affiliation country: Egypt

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Drug Design / Vascular Endothelial Growth Factor Receptor-2 / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Anticancer Agents Med Chem Journal subject: ANTINEOPLASICOS / QUIMICA Year: 2019 Document type: Article Affiliation country: Egypt